AGAytac Gulcu

Aytac Gulcu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Aytac Gulcu has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Grange‐Like Phenotype Associated With an RNF213 Pathogenic Variant: Expanding the Vasculopathy Spectrum

    by Serife Ozturk Yilmaz, Ayca Yigit, Sevcan Hatipoglu, Semra Gursoy, Aytac Gulcu, Tuncer Turhan, Mert Pekerbas, Alper Soylu, Ugur Ozbek, Ozlem Giray Bozkaya

    Grange syndrome, caused by biallelic loss‐of‐function variants in YY1AP1 , is characterized by multivascular stenoses, renovascular hypertension, brachydactyly, syndactyly, and mild cognitive impairment. Although RNF213 variants are typically associated with Moyamoya disease and systemic arterial stenosis, evidence suggests that pathogenic RNF213 variants may contribute to a broader vascular phenotype. We describe a 15‐year‐old girl with Moyamoya vasculopathy presenting with bilateral renal artery stenosis, brachydactyly, and intellectual disability. Her history included left‐arm weakness and seizures at 10 months of age. She underwent surgical revascularization at 1.5 and 3 years of age for Moyamoya disease. Upon evaluation for hypertension, the patient was diagnosed with bilateral renal artery stenosis. Physical examination revealed dysmorphic features including deep‐set eyes, up slanting palpebral fissures, a broad nasal bridge, low‐set, posteriorly rotated ears, a broad left thumb, brachydactyly, and syndactyly of the toes. Whole‐exome sequencing was negative; trio whole‐genome sequencing identified a de novo, likely pathogenic RNF213 variant (c.12341C > G). This case expands the phenotypic spectrum associated with RNF213 variants, presenting a Grange‐like phenotype. Our study highlights RNF213 as a candidate gene for such phenotypes. A negative YY1AP1 result does not exclude a Grange‐like phenotype, emphasizing the need for comprehensive genetic testing and early vascular surveillance.

  • Open Access

    Massive Recurrent Bleeding From Parastomal Caput Medusae

    by Aras Emre Canda, Semra Demirli Atici, Aytac Gulcu

    Ectopic variceal bleeding is a rare but life‐threatening complication of portal hypertension. For severe parastomal variceal hemorrhage unresponsive to conservative therapy, endovascular embolization is a safe, minimally invasive, repeatable, and effective life‐saving alternative, particularly in patients with portal hypertension and hepatic dysfunction.

  • Open Access

    Peripheral Blood Cell Changes And Outcomes After Partial Splenic Embolization For Hypersplenism İn Cirrhotic Patients

    by Süleyman Dolu, Göksel Bengi, Nilay Danış, Müjde Soytürk, İlKer Büyüktorun, Hüseyin Döngelli, Mücahit Özbilgin, Aytaç Gülcü, Orkun Sarıoğlu, İsMail Nafi Özdamar, et al.

    Background and Purpose: Partial splenic embolization is a common treatment for hypersplenism in patients with cirrhosis. In this investigation, we evaluated the effectiveness and safety of partial splenic embolization in patients with cirrhosis. Methods: We retrospectively investigated 17 patients with hypersplenism secondary to cirrhosis who underwent partial splenic embolization. Following partial splenic embolization, peripheral blood cell counts were measured at regular intervals over a period of twelve months.Post-procedural complications were recorded. Results: This study included 17 individuals, with a mean age of 54.5 ± 10 years. Hemoglobin, platelet, neutrophil, lymphocyte, and white blood cell counts showed statistically significant increases.when compared to the pre-procedure levels at each time point (pre-procedure vs. 1st day p

  • Recurrent perirenal hematomas and brachial plexopathy in a boy with familial Mediterranean fever associated polyarteritis nodosa

    by Belde Kasap-Demir, Alper Soylu, Aytaç Gülcü, Yiğit Göktay, Mehmet Atilla Türkmen, Salih Kavukçu